Tel: +86 (0)571 8102-5280 Email: sales@molcore.com
Language : English 中文版 日本語

Boric acid and catalyst

  1. Home
  2. Products
  3. Boric acid and catalyst
  • MC28H633 | 167023-19-0 | β-D-erythro-2-Hexulofuranosononitrile, 2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-2,3-dideoxy-4,6-bis-O-[(1,1-dimethylethyl)dimethylsilyl]- (9CI)

    167023-19-0

    β-D-erythro-2-Hexulofuranosononitrile, 2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-2,3-dideoxy-4,6-bis-O-[(1,1-dimethylethyl)dimethylsilyl]- (9CI)

  • MCU86628 | 246538-18-1 | β-D-erythro-Heptofuranuronic acid, 1,2,3,6-tetradeoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(phenylmethoxy)carbonyl]amino]-, ethyl ester, (5ξ)- (9CI)

    246538-18-1

    β-D-erythro-Heptofuranuronic acid, 1,2,3,6-tetradeoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(phenylmethoxy)carbonyl]amino]-, ethyl ester, (5ξ)- (9CI)

  • MC286G27 | 246538-35-2 | β-D-erythro-Heptofuranuronic acid, 5-O-[bis(4-methoxyphenyl)phenylmethyl]-1,2,3,6-tetradeoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(phenylmethoxy)carbonyl]amino]-, ethyl ester, (5ξ)- (9CI)

    246538-35-2

    β-D-erythro-Heptofuranuronic acid, 5-O-[bis(4-methoxyphenyl)phenylmethyl]-1,2,3,6-tetradeoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-[[(phenylmethoxy)carbonyl]amino]-, ethyl ester, (5ξ)- (9CI)

  • MCR86618 | 910295-61-3 | β-D-erythro-Hexofuranuronic acid, 1,2,5-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-[(1,1-dimethylethyl)dimethylsilyl]- (9CI)

    910295-61-3

    β-D-erythro-Hexofuranuronic acid, 1,2,5-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-[(1,1-dimethylethyl)dimethylsilyl]- (9CI)

  • MC2H6615 | 49539-25-5 | β-D-erythro-Hexofuranuronic acid, 1,2,5-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)- (9CI)

    49539-25-5

    β-D-erythro-Hexofuranuronic acid, 1,2,5-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)- (9CI)

  • MC286S00 | 156737-12-1 | β-D-erythro-Hexofuranurononitrile, 1,2,5-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-[(1,1-dimethylethyl)dimethylsilyl]- (9CI)

    156737-12-1

    β-D-erythro-Hexofuranurononitrile, 1,2,5-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-[(1,1-dimethylethyl)dimethylsilyl]- (9CI)

  • MC286H99 | 164254-08-4 | β-D-erythro-Hexofuranuronic acid, 1,2,5-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)

    164254-08-4

    β-D-erythro-Hexofuranuronic acid, 1,2,5-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-[(1,1-dimethylethyl)diphenylsilyl]- (9CI)

  • MC286Z14 | 208175-44-4 | β-D-erythro-Pentofuranuronic acid, 1-[4-(acetylamino)-2-oxo-1(2H)-pyrimidinyl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-[(phenylmethoxy)methyl]-, methyl ester (9CI)

    208175-44-4

    β-D-erythro-Pentofuranuronic acid, 1-[4-(acetylamino)-2-oxo-1(2H)-pyrimidinyl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-[(phenylmethoxy)methyl]-, methyl ester (9CI)

  • MCD86507 | 208175-46-6 | β-D-erythro-Pentofuranuronic acid, 1-[2-(acetylamino)-1,6-dihydro-6-oxo-9H-purin-9-yl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-[(phenylmethoxy)methyl]-, methyl ester (9CI)

    208175-46-6

    β-D-erythro-Pentofuranuronic acid, 1-[2-(acetylamino)-1,6-dihydro-6-oxo-9H-purin-9-yl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-[(phenylmethoxy)methyl]-, methyl ester (9CI)

  • MC286C06 | 208175-48-8 | β-D-erythro-Pentofuranuronic acid, 1-[6-(benzoylamino)-9H-purin-9-yl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-[(phenylmethoxy)methyl]-, methyl ester (9CI)

    208175-48-8

    β-D-erythro-Pentofuranuronic acid, 1-[6-(benzoylamino)-9H-purin-9-yl]-1,2-dideoxy-3-O-[(1,1-dimethylethyl)dimethylsilyl]-4-C-[(phenylmethoxy)methyl]-, methyl ester (9CI)

© Copyright 2015-2025 Hangzhou MolCore BioPharmatech Co.,Ltd. All rights reserved.